googlefd16b42746daa692.html

NCIC publications - surveillance and epidemiology

2021

Risk factors for candidaemia: A prospective multi-centre case-control study.

Keighley CL, Pope A, Marriott DJE, Chapman B, Bak N, Daveson K, Hajkowicz K, Halliday C, Kennedy K, Kidd S, Sorrell TC, Underwood N, van Hal S, Slavin MA, Chen SC.

Mycoses. 2021 Mar;64(3):257-263. Check Access


Infection related mortality in adults and children undergoing allogeneic hematopoietic cell transplantation: An Australian registry report

Lindsay J, Kerridge I, Wilcox L, Tran S, O'Brien TA, Greenwood M, Chen SC-A, Kong DCM, Pergam SA, Liu C, Slavin MA.

Transplantation and Cellular Therapy. 2021; [epub ahead of print]. Check Access


Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016

Leung VKY, Fox A, Carolan LA, Aban M, Laurie KL, Druce J, Deng Y-M, Slavin MA, Marshall C, Sullivan SG.

Vaccine. 2021; [epub ahead of print]. Check Access


Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia

Sherry NL, Lee RS, Gorrie CL, Kwong JC, Stuart RL, Korman TM, Marshall C, Higgs C, Chan HT, Graham M, Johnson PDR, MJ Leroi, Reed C, Richards MJ, Slavin MA, Worth LJ, Howden BP, Grayson ML.

Infect Control Hosp Epidemiol. 2021;42(5):573-581. Check Access


Use of a Victorian statewide surveillance program to evaluate the burden of healthcare‐associated Staphylococcus aureus bacteraemia and Clostridioides difficile infection in patients with cancer

Valentine JC, Hall L, Verspoor KM, Gillespie E, Worth LJ.

Intern Med J. 2021; [epub ahead of print]. Check Access


Epidemiology and risks of infections in patients with multiple myeloma managed with new generation therapies

Lim C, Sinha P, Harrison SJ, Quach H, Slavin MA, Teh BW.

Clin Lymphoma Myeloma Leuk. 2021; [epub ahead of print]. Check Access


Quality of inpatient antimicrobial use in hematology and oncology patients

Douglas AP, Hall L, James RS, Worth LJ, Slavin MA, Thursky KA.

Infect Control Hosp Epidemiol. 2021; [epub ahead of print]. Check Access

 

2020

New names for fungi of medical importance: can we have our cake and eat it too?

Kidd SE, Halliday CL, McMullan B, Chen SC-A, Elvy J.

J Clin Microbiol. 2020; [epub ahead of print]. Check Access


The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA.

J Allergy Clin Immunol. 2020;146(3):518-534.e1. Check Access


Classification performance of administrative coding data for detection of invasive fungal infection in paediatric cancer patients

Valentine JC, Worth LJ, Verspoor KM, Hall L, Yeoh DK, Thursky KA, Clark JE, Haeusler GM.

PLoS ONE. 2020;15(9):e0238889. Check Access


Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study

Lim C, Sinha P, Harrison S, Quach H, Slavin MA, Teh BW.

Mycoses. 2020; [epub ahead of print]. Check Access


Bacterial Urinary Tract Infections And Asymptomatic Bacteriuria In Kidney Transplant Recipients

Coussement J, Kaminski H, Scemla A, Manuel O.

Curr Opin Infect Dis. 2020; [epub ahead of print]


ALTERATIONS IN SMELL OR TASTE – CLASSIC COVID-19?

Trubiano JA, Vogrin S, Kwong JC, Holmes NE.

Clin Infect Dis. 2020;ciaa655 [epub ahead of print]. Check Access


Very late‐onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

Khan SF, Yong MK, Slavin MA, Hughes P, Sasadeusz J.

Transpl Infect Dis. 2020; [epub ahead of print]. Check Access


Ibrutinib And Invasive Fungal Infections: The Known, The Unknown And The Known Unknowns

Reynolds G, Slavin MA, Teh BW.

Leuk Lymphoma. 2020; [epub ahead of print]. Check Access


Candida Auris In An Australian Health Care Facility: Importance Of Screening High Risk Patients

Worth LJ, Harrison SJ, Dickinson M, Diemen A, Breen J, Harper S, Marshall C, Williamson DA, Thursky KA, Slavin MA.

Med J Aust. 2020;212(11):510-511.e1. Check Access


Sepsis In Cancer: A Question Of Definition

Valentine JC, Thursky KA, Worth LJ.

Aust N Z J Public Health. 2020;44(3):245. Check Access


Burden And Clinical Outcomes Of Hospital-Coded Infections In Patients With Cancer: An 11-Year Longitudinal Cohort Study At An Australian Cancer Centre

Valentine JC, Hall L, Spelman T, Verspoor KM, Seymour JF, Rischin D, Thursky KA, Slavin MA, Worth LJ.

Support Care Cancer. 2020;28(12):6023-6034. Check Access


Epidemiology, Treatment And Outcomes Of Bloodstream Infection Due To Vancomycin-Resistant Enterococci In Cancer Patients In A VanB Endemic Setting

Xie O, Slavin MA, Teh BW, Bajel A, Douglas AP, Worth LJ.

BMC Infect Dis. 2020;20(1):228. Check Access


Clinical Characteristics And Outcomes Of Invasive Lomentospora Prolificans Infections: Analysis Of Patients In The FungiScope® Registry

Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Slavin MA, Hoenigl M.

Mycoses. 2020;63(5):437-442. Check Access


Cryptococcal Infection In Patients With Haematological And Solid Organ Malignancy In The Era Of Targeted And Immune-Based Therapies

Madigan V, Smibert O, Chen S, Trubiano JA, Slavin MA, Teh BW.

Clin Microbiol Infect. 2020;26(4):519-521. Check Access

 

2019

hospital-coded infections in patients with cancer: evaluating disease burden and outcomes in Australian cancer patients

Valentine JC, Hall L, Verspoor KM, Spelman T, Worth LJ.

Infect Dis Health. 2019;24(Supplement_1):S2. Check Access


Appropriateness Of Surgical Antimicrobial Prophylaxis Practices In Australia

Ierano C, Thursky K, Marshall C, Koning S, James R, Johnson S, Imam N, Worth LJ, Peel T.

JAMA Netw Open. 2019;2(11):e1915003. Check Access


Epidemiology And Risks For Infection Following Cytoreductive Surgery And Hyperthermic Intra-Peritoneal Chemotherapy

Smibert OC, Slavin MA, Teh B, Heriot AG, Penno J, Ismail H, Thursky KA, Worth LJ.

Support Care Cancer. 2019;28(6):2745-2752. Check Access


The Economic And Health Utilization Cost Of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Yong MK, Tio SY, Valentine J, Sasadeusz J, Chee LCY, Bajel A, Ritchie D, Slavin M.

Blood. 2019;134(Supplement_1):3437. Check Access


Invasive Fungal Infections In Children With Acute Lymphoblastic Leukaemia: Results From Four Australian Centres, 2003-2013

Wang SS, Kotecha RS, Bernard A, Blyth CC, McMullan BJ, Cann MP, Yeoh DK, Bartlett AW, Ryan AL, Moore AS, Bryant PA, Clark J, Haeusler GM.

Pediatr Blood Cancer. 2019;66(10):e27915. Check Access


Sepsis Incidence And Mortality Are Underestimated In Australian Intensive Care Unit Administrative Data

Valentine JC, Haeusler G, Worth L, Thursky K.

Med J Aust. 2019;210(4):188-188.e1. Check Access


The Current Scope Of Healthcare-Associated Infection Surveillance Activities In Hospitalized Immunocompromised Patients: A Systematic Review

Valentine JC, Hall L, Verspoor KM, Worth LJ.

Int J Epidemiol. 2019;48(6):1768-1782. Check Access


High Prevalence Of Antibiotic Allergies In Cladribine-Treated Patients With Hairy Cell Leukemia - Lessons For Immunopathogenesis And Prescribing

Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA.

Leuk Lymphoma. 2019;60(14):3455-3460. Check Access


Fatal Disseminated Visceral Varicella Zoster Virus Infection In A Renal Transplant Recipient

Loftus MJ, Yong MK, Wilson S, Peleg AY.

Transpl Infect Dis. 2019;21(3):e13062. Check Access


Candidaemia And A Risk Predictive Model For Overall Mortality: A Prospective Multicentre Study

Keighley C, Chen SC, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA.

BMC Infect Dis. 2019;19(1):445. Check Access


Auditing Fungal Disease In Leukemia Patients In A Tertiary Care Center: Opportunities And Challenges For An Antifungal Stewardship Program

Paige E, Haywood P, Xie M, Worth L, Thursky K, Urbancic K, Bajel A, Slavin M.

Leuk Lymphoma. 2019;60(10):2373-2383. Check Access


Immunosuppressed Returned Traveler With Ulcerating Skin Lesion And Fever

Hall V, Trubiano JA, Kwong JC, Williams DS, Holmes NE.

Clin Infect Dis. 2019;68(10):1747-1749. Check Access


Prognostic Factors In 264 Adults With Invasive Scedosporium Spp. And Lomentospora Prolificans Infection Reported In The Literature And FungiScope®

Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA, Bachmann B, Borchert K, Burchardt A, Chakrabarti A, Christopeit M, Fasih N, Hekmat K, Hernández Rupérez B, Kemmerling B, Kessel J, Jyoti Kindo A, Klimko N, Krause R, Lass-Flörl C, Levesque E, Lockhart S, Steinmann J, Maritati A, Markiefka B, Martín Gómez MT, Meis J, Oksi J, Pagano L, Ramos Martinez A, Reischies F, Soler Palacin P, Vermeulen E.

Crit Rev Microbiol. 2019;45(1):1-21. Check Access


The Contemporary Management And Clinical Outcomes Of Mucormycosis: A Systematic Review And Meta-Analysis Of Case Reports

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, Kong DCM.

Int J Antimicrob Agents. 2019;53(5):589-597. Check Access


High Rates Of Proven Invasive Fungal Disease With The Use Of Ibrutinib Monotherapy For Relapsed Or Refractory Chronic Lymphocytic Leukemia

Teh BW, Chui W, Handunnetti S, Tam C, Worth LJ, Thursky KA, Slavin MA.

Leuk Lymphoma. 2019;60(6):1572-1575. Check Access


The Epidemiology And Clinical Manifestations Of Mucormycosis: A Systematic Review And Meta-Analysis Of Case Reports

Jeong W, Keighley C, Wolfe R, Leng Lee W, Slavin MA, Kong DCM, Chen SC.

Clin Microbiol Infect. 2019;25(1):26-34. Check Access

 

2018

Antifungal Stewardship: Developments In The Field

Urbancic KF, Thursky K, Kong DCM, Johnson PDR, Slavin MA.

Curr Opin Infect Dis. 2018;31(6):490-498. Check Access


Invasive Fungal Disease And Cytomegalovirus Infection: Is There An Association?

Yong MK, Slavin M, Kontoyiannis DP.

Curr Opin Infect Dis. 2018;31(6):481-489. Check Access


Infections In Patients With Chronic Lymphocytic Leukaemia: Mitigating Risk In The Era Of Targeted Therapies

Teh BW, Tam CS, Handunnetti S, Worth LJ, Slavin MA.

Blood Rev. 2018;32(6):499-507. Check Access


Viral Respiratory Tract Infections In Allogeneic Hematopoietic Stem Cell Transplantation Recipients In The Era Of Molecular Testing

Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW.

Biol Blood Marrow Transplant. 2018;24(7):1490-1496. Check Access


Immune Monitoring For CMV In Transplantation

Yong MK, Lewin SR, Manuel O.

Curr Infect Dis Rep. 2018;20(4):4. Check Access


Factors Contributing To Declination Of Annual Influenza Vaccination By Healthcare Workers Caring For Cancer Patients: An Australian Experience

Surtees TC, Teh BW, Slavin MA, Worth LJ.

Vaccine. 2018;36(14):1804-1807. Check Access

 

2017

Candida And Invasive Mould Diseases In Non-Neutropenic Critically Ill Patients And Patients With Haematological Cancer

Colombo AL, de Almeida Júnior JN, Slavin MA, Chen SC, Sorrell TC.

Lancet Infect Dis. 2017;17(11):e344-e356. Check Access


Incidence, Etiology And Timing Of Infections Following Azacitidine Therapy For Myelodysplastic Syndromes

Trubiano JA, Dickinson M, Thursky KA, Spelman T, Seymour JF, Slavin MA, Worth LJ.

Leuk Lymphoma. 2017;58(10):2379-2386. Check Access


A Mycoses Study Group International Prospective Study Of Phaeohyphomycosis: An Analysis Of 99 Proven/Probable Cases

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017;4(4):ofx200. Check Access


Risks Factors And Outcomes Of Clostridium Difficile Infection In Patients With Cancer: A Matched Case-Control Study

Hebbard AIT, Slavin MA, Reed C, Trubiano JA, Teh BW, Haeusler GM, Thursky KA, Worth LJ.

Support Care Cancer. 2017;25(6):1923-1930. Check Access


Influenza Vaccination Responses: Evaluating Impact Of Repeat Vaccination Among Health Care Workers

Leung VKY, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA, Sullivan SG.

Vaccine. 2017;35(19):2558-2568. Check Access


Changing Epidemiology Of Candidaemia In Australia

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group.

J Antimicrob Chemother. 2017;72(4):1103-1108.  Check Access


Epidemiology Of Bloodstream Infections In Patients With Myeloma Receiving Current Era Therapy

Teh BW, Harrison SJ, Slavin MA, Worth LJ.

Eur J Haematol. 2017;98(2):149-153. Check Access

googlefd16b42746daa692.html